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osting by EAbstract Diabetic retinopathy has an enormous impact on visual function, even before permanent
visual acuity loss. Moreover, adequate functional tests are mandatory to diagnose and follow dia-
betic patients treated for diabetic macular edema (DME). More precisely, the visual function safety
proﬁle of any therapy for DME should be accurately investigated. Microperimetry offers the pos-
sibility to obtain an exact fundus-related quantiﬁcation of retinal sensitivity, and it is changing the
current approach to the functional investigation of diabetic retinopathy.
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lsevier1. Introduction
Diabetic retinopathy is one of the major causes of permanent
visual (acuity) loss in the working population. Moreover, the
prevalence of diabetes mellitus is dramatically increasing
worldwide. Visual loss is commonly quantiﬁed by a full con-
trast visual acuity test (by Snellen or ETDRS charts). Unfortu-
nately, this full-contrast visual acuity test doesn’t reﬂect the
real visual functional abnormalities due to the retinal involve-
ment secondary to diabetes mellitus. Moreover, subtle and
precocious neurosensory visual abnormalities have been
quantiﬁed in diabetic patients in order to detect early visual
dysfunction, even before the onset of clinically detectable
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among diabetic subjects a population at higher risk of develop-
ing vision threatening retinopathy (Bresnick, 1986; Midena
et al., 1990). Psychophysical visual function testing may reﬂect
the neural activity of the whole visual pathway, but it is known
that psychophysical tests are valuable clinical indicators of ret-
inal function derangements induced by the metabolic changes
secondary to diabetes mellitus. In fact, in diabetic patients
impaired vision in dim light and difﬁculties in recognizing
the contour of objects in low contrast conditions are common
complaints even with good visual acuity and full visual ﬁelds
(Hyva¨rinen et al., 1983). Visual acuity is still considered the
gold standard in clinical practice of vision testing, but it does
not entirely reﬂect functional vision. Functional vision de-
scribes the impact of sight on the quality of life that represents
the patient’s point of view (Sharma et al., 2005; Owsley and Slo-
ane, 1987; Midena, 2006). This approach is better quantiﬁed
using all available psychophysical tests, mainly analyzing fun-
dus-related retinal sensitivity threshold. This paper reviews the
current application of fundus-related perimetry, better known
as microperimetry, in the diagnosis and follow-up of diabetic
retinopathy.2. Microperimetry (fundus-related perimetry)
Perimetry encompasses the assessment of differential light
threshold of retinal locations from the fovea to the pre-
planned periphery. Static perimetry is particularly useful for
detailed probing in carefully selected areas and represents the
current cornerstone of visual ﬁeld testing. Standard threshold
static automated perimetry quantiﬁes the differential light
threshold required to detect a static white light stimulus in
the visual ﬁeld. Since standard threshold perimetry uses a static
achromatic stimulus, it is thought to non-selectively evoke
both major groups of retinal ganglion cells. Newer technolo-
gies are aimed at earlier detection of subtle deﬁcits and enhanc-
ing diagnostic accuracy. In diabetic macular edema (DME),
visual acuity loss is quite relevant and irreversible when long
lasting edema involves the center of the macula; in these cases
the outcome of laser treatment is poor. But, before the loss of
visual acuity is reported by patients, they may suffer from
other disturbances of visual function such as: waviness, blur-
ring, relative scotoma and decrease of contrast sensitivity
which are not assessed and quantiﬁed in routine examination.
Therefore, a visual function test aimed at identifying vision
threatening retinopathy before visual acuity is affected would
be of great value. One possible approach may be to identify de-
creased sensitivity in central and paracentral areas using
microperimetry (Midena, 2006). As elegantly stated by Sunnes
et al., conventional visual ﬁeld examination is inadequate for
the accurate functional evaluation of macular diseases and
detection of small scotoma, particularly when foveal function
is compromised and the patient may have unstable and
extrafoveal ﬁxation (Sunness et al., 1995). Accuracy of the con-
ventional visual ﬁeld rests on the assumption that ﬁxation is
foveal and stable. Moreover, the detection of the site and sta-
bility of retinal ﬁxation (foveal or extrafoveal) and the quanti-
ﬁcation of retinal threshold over small and discrete retinal
lesions are beyond the possibilities of conventional, automatic
and non automatic perimetry (Midena and Radin, 2006). The
integration of retinal details with function has been achievedby fundus-related perimetry, more widely known as microperi-
metry. Microperimetry allows for the exact topographic corre-
lation between fundus abnormalities and corresponding
functional alterations by integration, with different methods,
of differential light threshold (more commonly known as reti-
nal sensitivity) and fundus imaging. It also allows to quantify
ﬁxation characteristics, by exactly deﬁning location and stabil-
ity of any foveal or extrafoveal (PRL: preferred retinal locus)
ﬁxation site, as well as determination of size, site and shape
of scotoma. Moreover, the possibility of an automatic fol-
low-up examination (using the microperimeter MP1, Nidek
Co, Japan) which allows the evaluation of exactly the same ret-
inal points tested at the baseline, regardless any change in ﬁx-
ation characteristics is a valuable tool of this technique, mainly
in the evaluation of treatment outcome. Microperimetry offers
several advantages versus standard perimetry in the quantiﬁca-
tion of macular sensitivity, such as: direct real time fundus con-
trol; direct correlation between sensitivity and fundus details;
detection of central microscotomata; continuos monitoring
of ﬁxation. The original Scanning Laser Ophthalmoscope
(SLO, Rodenstock, Germany) was the ﬁrst instrument com-
bining static perimetric testing and simultaneous observation
of the fundus. SLO allowed a real-time examination by an
infrared (IR) source of the retina and allowed the manual pro-
jection of visual stimuli of different shapes, sizes and intensities
over selected retinal areas. The sensitivity map, obtained
according to the stimulation pattern (in dB or pseudocolors),
was available at the end of the examination. This map con-
tained the ﬁxation area, the ﬁxation target, and the threshold
data. This instrument is no more commercially available.
With the introduction of a new microperimeter, a liquid
crystal display (LCD) microperimeter (MP1) with a coupled
color fundus camera, visualization of color fundus details al-
lows to directly report functional data onto clinical fundus im-
age and automatic tests are also obtained. MP-1
microperimeter has both an infrared and a color fundus cam-
era, as well as an automatic real-time tracking system that al-
lows for a full automatic retinal ﬁxation and threshold
determination as well as automatic follow-up and differential
maps determination, independently from ﬁxation characteris-
tics. The main technical characteristics of this instrument have
been previously described in detail (Vujosevic et al., 2006;
Midena et al., 2004; Midena et al., 2007). Roschneider et al.
compared MP-1 and SLO microperimeters and found that
both instruments analyzed retinal sensitivity and ﬁxation char-
acteristics, and the results obtained from both instruments
were directly comparable. However, MP-1 is superior to
SLO due to the automatic real-time alignment system, a larger
ﬁeld of (fundus) view (44 · 36 MP1 versus 33 · 21 SLO)
and color image (Rohrschneider et al., 2005).
The most relevant characteristics of advanced microperime-
try performed with the MP-1 microperimeter may be brieﬂy
summarized as follows:
 Exact fundus-related stimulation
 Automatic eye-tracking system
 Automatic static and kinetic stimulation (with standardized
or customized grids and centration)
 Normative age-related database (Midena et al., 2010)
 Age-related differential maps (local defect determination,
shallow defects determination, etc. . .)
 Automatic follow-up and differential maps
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 Morpho/functional relationship investigation (overlapping
of sensitivity maps over different types of fundus images)
MP-1 microperimetry is a mesopic test that requires a 5–
10 min dark light adaptation before starting the examination.
In the last 15 years, microperimetry has been successfully
used in the diagnosis and follow-up of different macular disor-
ders, including: age-related macular degeneration, myopic
maculopathy, macular dystrophies and diabetic macular ede-
ma (DME) (Midena et al., 2004; Mori et al., 2001; Rohrschne-
ider et al., 2000; Mori et al., 2002; Rohrschneider et al., 1997;
Sunness et al., 1996; Kube et al., 2005; Loewenstein et al.,
1998; Midena, 2005; Varano et al., 2005). In DME microperi-
metry has been used for: the quantiﬁcation of macular sensitiv-
ity; the correlation of macular sensitivity to macular thickness,
visual acuity and fundus autoﬂuorescence data; and the ﬁxa-
tion patterns determination in different stages and types of
edema.
Different studies report the correlation between retinal sen-
sitivity, determined with microperimetry, and VA in patients
with CSME (Vujosevic et al., 2006; Rohrschneider et al.,
2000; Okada et al., 2006). Moreover, reduced retinal sensitivity
is related to increasing retinal thickness (Vujosevic et al., 2006;
Kube et al., 2005; Okada et al., 2006). In a study published by
Vujosevic et al. a signiﬁcant inverse relationship was found, in
patients with CSME, between retinal sensitivity and normal-
ized retinal thickness values obtained with OCT, with a decay
of 0.83 dB (p< 0.0001) for every 10% of deviation of retinal
thickness from the normal values (Vujosevic et al., 2006).
(Fig. 1). This means that normalized macular thickness better
copes with macular function, than any absolute value (Vujos-
evic et al., 2006). Microperimetry seems to represent a better
functional testing than BCVA for quantifying visual function
in diabetic patients, because it incorporates a functional mea-
sure that may potentially supplement the predictive value of
OCT and visual acuity (Vujosevic et al., 2006; Okada et al.,
2006; Vujosevic et al., 2008).
Besides retinal sensitivity, microperimetry allows to quan-
tify retinal ﬁxation characteristics. Fixation characteristics
(location and stability) are relevant parameters for under-
standing patient’s quality of vision, especially reading ability,Figure 1 Microperimetry map (in decibels) superimposed onto
the color fundus image in a case of clinically signiﬁcant diabetic
macular edema. Decrease of retinal sensitivity is shown on the
temporal side of the macular region.and its knowledge may be important in planning laser treat-
ment (Rohrschneider et al., 2000; Vujosevic et al., 2008; Møller
and Bek, 2003; Møller et al., 2005). Reading ability better cor-
relates with subjective quality of vision rather than distant vi-
sual acuity (Rohrschneider et al., 2000). Whereas different
studies agree that macular sensitivity deteriorates in patients
with DME, data about ﬁxation characteristics are quite con-
trasting (Vujosevic et al., 2006; Mori et al., 2001; Rohrschneid-
er et al., 2000; Kube et al., 2005; Okada et al., 2006; Carpineto
et al., 2007). Kube et al. found decreased ﬁxation stability in
patients with DME using SLO-microperimetry (Kube et al.,
2005). Carpineto et al. found that all eyes with eccentric or
unstable ﬁxation had cystoid DME (Carpineto et al., 2007).
Vujosevic et al. found that ﬁxation patterns are not signiﬁ-
cantly inﬂuenced by either topographical extension of edema
(focal or diffuse) or by the OCT classiﬁcation of edema (Vujos-
evic et al., 2008). Moreover, ﬁxation pattern was not signiﬁ-
cantly inﬂuenced by the presence of subfoveal serous
neuroretinal detachment, showing a different ﬁxation behavior
compared to age related macular degeneration (Midena et al.,
2004; Vujosevic et al., 2008). The only parameter inﬂuencing
ﬁxation was the presence of subfoveal hard exudates. In these
cases, the knowledge of ﬁxation location and stability is funda-
mental in order to avoid complications due to the photocoag-
ulation of newly developed ﬁxation area (Fig. 2).
The duration of diabetic macular edema, which cannot be
exactly quantiﬁed in a cross sectional study, might have a rel-
evant impact on the survival and/or functional reserve of mac-
ular cells undergoing mechanical and toxic stress induced by
edema and this may explain the difference in ﬁxation results
described above. It seems that in patients with DME, the dam-
age to photoreceptor occurs as a late phenomenon, and prob-
ably is not related to intraretinal cysts formation. In diabetic
retinopathy, retinal neurodegeneration may precede photore-
ceptor loss, as previously reported (Vujosevic and Midena,
2006). Therefore, microperimetry may be of value in predicting
the functional outcome of diabetic macular edema after inter-
ventions that seem equally effective in restoring normal fovealFigure 2 Microperimrtry map (in decibels) superimposed onto
the color fundus image in a case of severe clinically signiﬁcant
diabetic macular edema with large hard exudates. Over hard
exudates the retinal shows some dense scotomatous zones.
Fixation (tiny light blue spots centered onto the ﬁxation target,
red circle) is still stable and central.
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randomized and prospective study conducted by Vujosevic
et al. These authors have demonstrated that subthreshold
micropulse diode laser is as effective as modiﬁed ETDRS pho-
tocoagulation in reducing central retinal thickness. But with
subthreshold treatment retinal macular retinal sensitivity stabi-
lizes or improves, whereas with standard photocoagulation it
signiﬁcantly deteriorates, manifesting as progressive microsco-
tomata (Vujosevic et al., 2010a).
That microperimetry is also useful in the understanding of
pathophysiology of diabetic retinopathy, more precisely dia-
betic macular edema, has been very recently demonstrated
by Vujosevic et al., who analyzed DME using both fundus
autoﬂuorescence and microperimetry, as functional correlates
(Vujosevic et al., 2011). They have demonstrated that in
DME fundus autoﬂuorescence increases in 75% of affected
eyes, and that these hyperﬂuorescent areas are characterized
by reduced retinal sensitivity. Moreover they have hypothe-
sized that increased fundus autoﬂuorescence may depend on
activated retinal glial cells, introducing the role of retinal glial
cells in the pathophysiology of visual loss in diabetes.
3. Conclusion
Diabetes has a relevant impact on visual function, up to
permanent visual acuity loss, when retinopathy is clinically
evident. Visual acuity cannot represent the only functional
way of quantifying visual function loss. Microperimetry has
the major advantage of integrating the functional parameter
(sensitivity threshold) to the morphologic status of the retina
(biomicroscopy, ﬂuorescein angiography, OCT and fundus
autoﬂuorescence). This approach has shown the peculiar char-
acteristic of ﬁxation changes in diabetes, compared to age-
related macular degeneration, and the absolute safety of treat-
ing DME with a micropulse subthreshold diode laser versus
conventional laser photocoagulation. Microperimetry may
also contribute to the understanding of the pathophysiology
of early phases of diabetic retinopathy.
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